H19 is highly expressed in a majority of human cancers, including breast cancer, colorectal cancer, hepatocellular carcinoma, and gastric cancer [12–15], and overexpression of H19 is often correlated with poor prognosis of tumor patients [16, 17]. This evidence concerns the gene H19 and breast cancer.